Reduced Rivaroxaban Dose vs Dual Antiplatelet Therapy After Left Atrial Appendage Closure
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Circulation: Cardiovascular Interventions
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Reduced Rivaroxaban Dose Versus Dual Antiplatelet Therapy After Left Atrial Appendage Closure: ADRIFT a Randomized Pilot Study
Circ Cardiovasc Interv 2020 Jul 01;13(7)e008481, G Duthoit, J Silvain, E Marijon, G Ducrocq, A Lepillier, C Frere, SF Dimby, B Popovic, N Lellouche, I Martin-Toutain, C Spaulding, E Brochet, D Attias, J Mansourati, L Lorgis, D Klug, N Zannad, M Hauguel-Moreau, N Braik, S Deltour, A Ceccaldi, H Wang, N Hammoudi, D Brugier, E Vicaut, JM Juliard, G MontalescotFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.